Uprizna IV infusion 100mg, from Mitsubishi Tanabe Pharma, contains Inebilizumab (genetical recombination). This injectable drug (YJ code: 6399429A1026) is provided as 100mg in 10mL per bottle and is indicated for the treatment of neuromyelitis optica spectrum disorder (NMOSD).
Uprizna IV infusion 100mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).